These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 7484516

  • 1. Prognostic factors in advanced prostatic carcinoma treated with total androgen blockade. Flutamide with orchiectomy or with LHRH analogues. A Belgian multicentric study of 546 patients.
    Oosterlinck W, Mattelaer J, Derde MP, Kaufman L.
    Acta Urol Belg; 1995 Sep; 63(3):1-9. PubMed ID: 7484516
    [Abstract] [Full Text] [Related]

  • 2. PSA evolution: a prognostic factor during treatment of advanced prostatic carcinoma with total androgen blockade. Data from a Belgian multicentric study of 546 patients.
    Oosterlinck W, Mattelaer J, Casselman J, Van Velthoven R, Derde MP, Kaufman L.
    Acta Urol Belg; 1997 Oct; 65(3):63-71. PubMed ID: 9421938
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combined androgen blockade in the management of advanced prostate cancer: a sensible or ostensible approach.
    Ansari MS, Gupta NP, Hemal AK, Dogra PN, Seth A.
    Int J Urol; 2004 Dec; 11(12):1092-6. PubMed ID: 15663681
    [Abstract] [Full Text] [Related]

  • 7. Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancer.
    Crook J, Ludgate C, Malone S, Lim J, Perry G, Eapen L, Bowen J, Robertson S, Lockwood G.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):15-23. PubMed ID: 15337535
    [Abstract] [Full Text] [Related]

  • 8. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
    Suzuki H, Okihara K, Miyake H, Fujisawa M, Miyoshi S, Matsumoto T, Fujii M, Takihana Y, Usui T, Matsuda T, Ozono S, Kumon H, Ichikawa T, Miki T, Nonsteroidal Antiandrogen Sequential Alternation for Prostate Cancer Study Group.
    J Urol; 2008 Sep 01; 180(3):921-7. PubMed ID: 18635218
    [Abstract] [Full Text] [Related]

  • 9. Randomized comparison of total androgen blockade alone versus combined with weekly epirubicin in advanced prostate cancer.
    Pummer K, Lehnert M, Stettner H, Hubmer G.
    Eur Urol; 1997 Sep 01; 32 Suppl 3():81-5. PubMed ID: 9267791
    [Abstract] [Full Text] [Related]

  • 10. Characterization of patients with androgen-independent prostatic carcinoma whose serum prostate specific antigen decreased following flutamide withdrawal.
    Herrada J, Dieringer P, Logothetis CJ.
    J Urol; 1996 Feb 01; 155(2):620-3. PubMed ID: 8558675
    [Abstract] [Full Text] [Related]

  • 11. [Evolution and prognostic factors of adenocarcinomas of the prostate metastasizing at diagnosis].
    Arrizabalaga Moreno M, García González JI, Mora Durvan M, Díez Rodríguez JM, Esteban Artiaga R, Navarro Sebastián J, Castro Pita M, Paniagua Andrés P.
    Actas Urol Esp; 1997 Sep 01; 21(8):724-36. PubMed ID: 9412221
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association of body mass index with response and survival in men with metastatic prostate cancer: Southwest Oncology Group trials 8894 and 9916.
    Montgomery RB, Goldman B, Tangen CM, Hussain M, Petrylak DP, Page S, Klein EA, Crawford ED, Southwest Oncology Group.
    J Urol; 2007 Nov 01; 178(5):1946-51; discussion 1951. PubMed ID: 17868721
    [Abstract] [Full Text] [Related]

  • 14. Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer.
    Fair WR, Betancourt JE.
    Mol Urol; 2000 Nov 01; 4(3):241-8;discussion 249-50. PubMed ID: 11062380
    [Abstract] [Full Text] [Related]

  • 15. [Progress of endocrine therapy for prostate cancer and results].
    Kanetake H.
    Gan To Kagaku Ryoho; 1996 Mar 01; 23(4):413-7. PubMed ID: 8678491
    [Abstract] [Full Text] [Related]

  • 16. Serum markers as a predictor of response duration and patient survival after hormonal therapy for metastatic carcinoma of the prostate.
    Smith JA, Lange PH, Janknegt RA, Abbou CC, deGery A.
    J Urol; 1997 Apr 01; 157(4):1329-34. PubMed ID: 9120932
    [Abstract] [Full Text] [Related]

  • 17. Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10.
    Shipley WU, Desilvio M, Pilepich MV, Roach M, Wolkov HB, Sause WT, Rubin P, Lawton CA.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1162-7. PubMed ID: 16427211
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment.
    Köllermann J, Weikert S, Schostak M, Kempkensteffen C, Kleinschmidt K, Rau T, Pantel K.
    J Clin Oncol; 2008 Oct 20; 26(30):4928-33. PubMed ID: 18794550
    [Abstract] [Full Text] [Related]

  • 19. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS, Ayala G, Aguilar L, Mai WY, Timme TL, Vlachaki MT, Miles B, Kadmon D, Wheeler T, Caillouet J, Davis M, Carpenter LS, Lu HH, Chiu JK, Woo SY, Thompson T, Aguilar-Cordova E, Butler EB.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1520-9. PubMed ID: 15050332
    [Abstract] [Full Text] [Related]

  • 20. [Prognosis significance of prostatic markers in patients with prostatic adenocarcinoma undergoing total hormonal blockade].
    Regueiro López JC, Ruiz Alvarez Cienfuegos F, Leva Vallejo M, Requena Tapia MJ, Merchan García JA, Prieto Castro R, Alvarez Kindelan J.
    Actas Urol Esp; 1995 May 01; 19(5):357-62. PubMed ID: 8659288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.